Old Age, B Cell Function and Count Are the Critical Factors for Predicting Infection Risk in Patients With Autoimmune Rheumatic Diseases Undergoing Immunosuppression: A Cohort Study

被引:0
|
作者
Prakruthi, Jaladhar [1 ]
Kori, Devaraj [1 ]
Paramshetti, Shruti [1 ]
Ahamed, Sayid Fahad Nizar [1 ]
Panchagnula, Renuka [2 ]
Chandrashekara, S. [1 ]
机构
[1] Chanre Rheumatol & Immunol Ctr & Res, Bengaluru, Karnataka, India
[2] ChanRe Diagnost Lab, Bengaluru, Karnataka, India
关键词
ARD; IgG; immunosuppression; infection risk; neutrophil count; predictive parameters; TO-LYMPHOCYTE RATIO; TRANSPLANTATION; MANAGEMENT; NEUTROPHIL; SOCIETY; COMPLICATIONS; BIOMARKERS; MORTALITY;
D O I
10.1111/1756-185X.70187
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The study aims to assess baseline immune parameters that predict infection risk in autoimmune rheumatic disease (ARD) patients, with the goal of identifying high-risk individuals requiring immunosuppressive therapy escalation, based on infection rates during a one-year follow-up. Methods: The independent cohort study was conducted at a tertiary rheumatology center in India from December 2019 to March 2022. It included adult participants with ARDs undergoing immunosuppression. Ethics approval and informed consent were obtained. Patients underwent detailed history, clinical examination, and baseline investigations, which included complete hemogram, inflammatory parameters, immunoglobulin levels, cellular levels of the immune system, complement levels, and viral markers. Descriptive statistics, ANOVA, chi-squared tests, t-tests, and Fisher's exact tests were used. OLS regression analyses identified significant predictors of infection risk. They were followed up for a period of 1 year for any infection episodes. Results: Of the 106 participants recruited, 4 were excluded due to disease-related complications during the 3-month period of follow-up. The mean age of the participants was 38.21 +/- 12.73 years, with an average follow-up duration of 13.1 +/- 8.35 months. Among the remaining 102 participants, younger age was associated with a lower infection risk (OR 1.047). Protective factors against infection included lower levels of immunoglobulin E (IgE) (OR 0.379), methotrexate (MTX) use (OR 0.247), and biologics (OR 0.543). Conversely, lower Immunoglobulin G (IgG), elevated neutrophil counts (OR 3.588), higher neutrophil-to-lymphocyte ratios (NLR) (OR 2.577), low platelet counts (OR 0.546), and steroid use, which increased the risk fivefold (OR 5.686), were identified as risk factors. Ordinary Least Squares (OLS) regression analysis highlighted age, IgG levels, CD19 lymphocyte counts, WBC counts, and ESR as significant predictors of infection risk between the groups. Conclusion: Older age, low IgG, low B cell count (CD19) predict susceptibility to infections; high neutrophil counts, low platelets, and elevated NLR are key predictors of developing infection in ARDs patients. Careful monitoring and tailored treatment strategies are essential to reduce infection risks. Further research is needed in this direction to develop predictive algorithms.
引用
收藏
页数:8
相关论文
共 50 条
  • [11] Evaluating the risk of ischemic stroke at a young age in patients with autoimmune inflammatory rheumatic diseases: a population-based cohort study in Taiwan
    Huang, Ya-Chun
    Lai, Edward Chia-Cheng
    Liao, Tzu-Chi
    Weng, Meng-Yu
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [12] RISK OF HOSPITALIZED INFECTION IN CANCER PATIENTS WITH AUTOIMMUNE DISEASES: A SINGLE-CENTER COHORT STUDY
    Chen, H-H.
    Chen, D-Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1036 - 1036
  • [13] IMMUNOSUPPRESSION DOUBLES THE RISK OF COVID-19 INFECTION IN A LARGE VACCINATED COHORT OF 898 PATIENTS WITH RHEUMATIC DISEASES: IMPLICATIONS FOR FUTURE PRACTICE
    Cox, Natasha
    Bateman, James
    RHEUMATOLOGY, 2023, 62
  • [14] Risk factors and outcomes for repeat COVID-19 infection among patients with systemic autoimmune rheumatic diseases: A case-control study
    Kowalski, Emily N.
    Wang, Xiaosong
    Patel, Naomi J.
    Kawano, Yumeko
    Cook, Claire E.
    Vanni, Kathleen M. M.
    Qian, Grace
    Bade, Katarina J.
    Srivatsan, Shruthi
    Williams, Zachary K.
    Wallace, Zachary S.
    Sparks, Jeffrey A.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 63
  • [15] Paxlovid use is associated with lower risk of cardiovascular diseases in COVID-19 patients with autoimmune rheumatic diseases: a retrospective cohort study
    Weijie Wang
    Yu-Hsun Wang
    Ching-Hua Huang
    Tsung-Hsueh Hsieh
    Gema Hernández Ibarburu
    James Cheng-Chung Wei
    BMC Medicine, 22
  • [16] Paxlovid use is associated with lower risk of cardiovascular diseases in COVID-19 patients with autoimmune rheumatic diseases: a retrospective cohort study
    Wang, Weijie
    Wang, Yu-Hsun
    Huang, Ching-Hua
    Hsieh, Tsung-Hsueh
    Ibarburu, Gema Hernandez
    Wei, James Cheng-Chung
    BMC MEDICINE, 2024, 22 (01)
  • [17] Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study
    Patel, Naomi J.
    Wang, Xiaosong
    Fu, Xiaoqing
    Kawano, Yumeko
    Cook, Claire
    Vanni, Kathleen M. M.
    Qian, Grace
    Banasiak, Emily
    Kowalski, Emily
    Zhang, Yuqing
    Sparks, Jeffrey A.
    Wallace, Zachary S.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 58
  • [18] Patients with Systemic Autoimmune Rheumatic Diseases Remain at Risk for Hospitalization for COVID-19 Infection in the Omicron Era (2022-2024): A Retrospective Cohort Study
    Patel, Naomi
    King, Andrew
    Srivatsan, Shruthi
    Wang, Xiaosong
    Kowalski, Emily
    Vanni, Kathleen
    Qian, Grace
    Hanberg, Jennifer
    Bade, Katarina
    Saavedra, Alene
    Mueller, Kevin
    Williams, Zachary
    Johnson, Colebrook
    Negron, Madison
    Sparks, Jeffrey
    Wallace, Zachary
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 262 - 265
  • [19] Patients with systemic autoimmune rheumatic diseases remain at risk for hospitalisation for COVID-19 infection in the Omicron era (2022-2024): a retrospective cohort study
    Patel, Naomi J.
    Srivatsan, Shruthi
    Kowalski, Emily N.
    King, Andrew
    Wang, Xiaosong
    Vanni, Kathleen M. M.
    Qian, Grace
    Hanberg, Jennifer S.
    Bade, Katarina J.
    Saavedra, Alene A.
    Mueller, Kevin T.
    Hang, Buuthien
    Williams, Zachary K.
    Johnson, Colebrooke
    Negron, Madison
    Sparks, Jeffrey A.
    Wallace, Zachary S.
    RMD OPEN, 2025, 11 (01):
  • [20] Cancer Risk in Patients With Inflammatory Systemic Autoimmune Rheumatic Diseases A Nationwide Population-Based Dynamic Cohort Study in Taiwan
    Yu, Kuang-Hui
    Kuo, Chang-Fu
    Huang, Lu Hsiang
    Huang, Wen-Kuan
    See, Lai-Chu
    MEDICINE, 2016, 95 (18) : e3540